TOPLINE: Hippocampal atrophy is associated with cognitive decline over time, independent of amyloid-beta (Aβ) or tau, new research shows. Investigators note the findings suggest neurological disorders […]

In 2020, 54 million US adults with chronic pain managed their symptoms with a mix of medication and nonpharmacologic therapies but one in four relied on […]

Neurologists can play an important role in addressing the alarming increase in diabetic peripheral neuropathy (DPN), a troubling result of the obesity and type 2 diabetes […]

TOPLINE: Experiencing interpersonal racism in situations involving employment, housing, and the police raises the risk of stroke among Black women, a large cohort study suggests. METHODOLOGY: […]

TOPLINE: An intervention that provides palliative care training to community neurologists and specialized palliative care services to people with Parkinson’s disease (PD) via telehealth modestly improved […]

Final results of the pivotal twin phase 3 studies of gantenerumab in early Alzheimer’s disease (AD) confirm that the investigational antiamyloid agent lowered amyloid plaque burden […]

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS). Made by […]

PHOENIX — Early responders to zilucoplan, the newly approved medication for myasthenia gravis (MG), have sustained benefit for up to 60 weeks, new analyses show. “The […]

PHOENIX — Chemotherapy-induced peripheral neuropathy (CIPN) is linked to a decline in executive and neuromuscular function, a new finding that may increase the risk for compromised […]